Ausgabe 2/2010
Inhalt (23 Artikel)
Immunohistochemical detection of phosphorylated JAK-2 and STAT-5 proteins and correlation with erythropoietin receptor (EpoR) expression status in human brain tumors
M. Kondyli, G. Gatzounis, A. Kyritsis, J. Varakis, M. Assimakopoulou
IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines
Qinglin Liu, Gang Li, Ronghui Li, Jie shen, Qiaowei He, Lin Deng, Cai Zhang, Jian Zhang
Expression of CD74 in high grade gliomas: a potential role in temozolomide resistance
Gaspar J. Kitange, Brett L. Carlson, Mark A. Schroeder, Paul A. Decker, Bruce W. Morlan, Wenting Wu, Karla V. Ballman, Caterina Giannini, Jann N. Sarkaria
Genetic variants of folate and methionine metabolism and PCNSL incidence in a German patient population
Delia Kurzwelly, Stefan Knop, Markus Guenther, Juergen Loeffler, Agnieszka Korfel, Eckhard Thiel, Holger Hebart, Matthias Simon, Michael Weller, Michael Linnebank, Ulrich Herrlinger
A prospective study of temozolomide plus thalidomide during and after radiation therapy for pediatric diffuse pontine gliomas: preliminary results of the Korean Society for Pediatric Neuro-Oncology study
Chae-Yong Kim, Seung-Ki Kim, Ji Hoon Phi, Min Mi Lee, In Ah Kim, Il Han Kim, Kyu-Chang Wang, Hye-Lim Jung, Mee Jeong Lee, Byung-Kyu Cho
Natural history and management of low-grade glioma in NF-1 children
Pablo Hernáiz Driever, Stephan von Hornstein, Torsten Pietsch, Rolf Kortmann, Monika Warmuth-Metz, Angela Emser, Astrid K. Gnekow
Low-dose fotemustine for recurrent malignant glioma: a multicenter phase II study
Alessandra Fabi, Giulio Metro, Antonello Vidiri, Gaetano Lanzetta, Mariantonia Carosi, Stefano Telera, Marta Maschio, Michelangelo Russillo, Isabella Sperduti, Carmine M. Carapella, Francesco Cognetti, Andrea Pace
Osteopontin expression is a valuable marker for prediction of short-term recurrence in WHO grade I benign meningiomas
Kuan-Yin Tseng, Min-Huey Chung, Huey-Kang Sytwu, Horng-Mo Lee, Kuan-Yu Chen, Chen Chang, Chih-Kung Lin, Che-Hung Yen, Jia-Hong Chen, Gu-Jiun Lin, Hsin-I Ma, Yi-Shian Yeh, Da-Tong Ju, Ming-Ying Liu, Dueng-Yuan Hueng
Prognostic value of pretreatment 18F-FDG PET in patients with primary central nervous system lymphoma: SUV-based assessment
Nobuyuki Kawai, Hai-Ning Zhen, Keisuke Miyake, Yuka Yamamaoto, Yoshihiro Nishiyama, Takashi Tamiya
Inverse association of PPARγ agonists use and high grade glioma development
Christian Grommes, Devon S. Conway, Amer Alshekhlee, Jill S. Barnholtz-Sloan
Phase I/II dose escalation trial of concurrent temozolomide and whole brain radiation therapy for multiple brain metastasis
Tom Mikkelsen, Joe Anderson, Thomas J. Doyle, David Croteau, Rita Avedissian, Sam Ryu, Lonni Schultz
Expression of signal transducer and activator of transcription 3 (STAT3) in primary central nervous system diffuse large B-cell lymphoma: a retrospective analysis of 17 cases
Neerja Vajpayee, Juhi Hussain, Ioana Tolocica, Robert E. Hutchison, Ajeet Gajra
Factors influencing overall survival rates for patients with pineocytoma
Aaron J. Clark, Michael E. Sughrue, Michael E. Ivan, Derick Aranda, Martin J. Rutkowski, Ari J. Kane, Susan Chang, Andrew T. Parsa
A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas
David M. Peereboom, Jeffrey G. Supko, Kathryn A. Carson, Tracy Batchelor, Surasak Phuphanich, Glenn Lesser, Tom Mikkelson, Joy Fisher, Serena Desideri, Xiaoying He, Stuart A. Grossman
Erratum to: A phase I/II trial and pharmacokinetic study of ixabepilone in adult patients with recurrent high-grade gliomas
David M. Peereboom, Jeffrey G. Supko, Kathryn A. Carson, Tracy Batchelor, Surasak Phuphanich, Glenn Lesser, Tom Mikkelsen, Joy Fisher, Serena Desideri, Xiaoying He, Stuart A. Grossman
Epstein–Barr virus-associated primary central nervous system lymphomas in immunocompetent elderly patients: analysis for latent membrane protein-1 oncogene deletion and EBNA-2 strain typing
Yasuo Sugita, Mizuhiko Terasaki, Daisuke Niino, Koichi Ohshima, Arakawa Fumiko, Minoru Shigemori, Yasuharu Sato, Naoko Asano
Treatment-induced leukoencephalopathy in primary CNS lymphoma presenting as lower body parkinsonism
Antonio Milia, Giuseppina Pilia, Maria Giuseppina Mascia, Francesco Maria Manconi
Olfactory ensheathing cell tumour: case report and literature review
Ioana Darie, Laurent Riffaud, Stéphan Saïkali, Gilles Brassier, Abderrahmane Hamlat
Primary disseminated central neurocytoma: cytological and MRI evidence of tumor spread prior to surgery
Hoan Tran, Rafael Medina-Flores, Lisa A. Cerilli, Jeremy Phelps, Fa-Chyi Lee, Gene Wong, Paul Turner
Radiation-induced cerebellar high-grade glioma accompanied by meningioma and cavernoma 29 years after the treatment of medulloblastoma: a case report
Tomoya Kamide, Mitsutoshi Nakada, Yutaka Hayashi, Tomohide Suzuki, Yasuhiko Hayashi, Naoyuki Uchiyama, Tamotsu Kijima, Jun-ichiro Hamada
Meningeal chondroblastic osteosarcoma: case report and review of the literature
Emilie Romeo, Olivier Gisserot, Jean-Pierre de Jaureguiberry, Nicolas Desse, Jean-Baptiste Souraud, Naji Salem, Anthony Faivre, Corinne Bouvier, François Bertucci
Can high-dose fotemustine reverse MGMT resistance in glioblastoma multiforme?
Chiara Gallo, Carlo Buonerba, Giuseppe Di Lorenzo, Valeria Romeo, Sabino De Placido, Alfredo Marinelli
Rapid recurrence of craniopharyngioma following recombinant human growth hormone replacement
Takafumi Taguchi, Toshihiro Takao, Yasumasa Iwasaki, Kyonghon Pooh, Mizuho Okazaki, Kozo Hashimoto, Yoshio Terada